Background illustration for clinical trials search

Paid Clinical Trials Texas

Discover 5,035 paid clinical trials in Texas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

H. Pylori Eradication Using Pyklear in Adults in El Paso, Texas: a Pilot Study

for
H. Pylori Infection
Location: El Paso TX
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 18 - 65

Code: NCT01335334

Recruiting
Active & Responsive

A Study of YL201 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT05434234

Phase 1, Phase 2, Recruiting
Active & Responsive

Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women

for
Ovarian Cancer
Location: Providence RI, Morristown NJ, Rochester NY, Miami FL,
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 50 - 70+

Code: NCT00539162

Recruiting
Active & Responsive

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

for
Major Depressive Disorder
Location: Russells Mills MA, Farmington CT, Cedarhurst NY,
Sponsor: Syndeio Biosciences, Inc

Sex: All

Age: 18 - 64

Code: NCT06547489

Phase 2, Recruiting
Active & Responsive

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

for
Heart Failure, Cardiorenal Syndrome, Cardio-Renal Syndrome,
Location: Neptune City NJ, Brooklyn NY, New York NY,
Sponsor: Procyrion

Sex: All

Age: 21+

Code: NCT05677100

Not recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Featured

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

for
Chronic Lymphocytic Leukemia
Location: Providence RI, Worcester MA, New Haven CT, New York NY,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06428019

Phase 3, Recruiting
Featured

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

for
Non-Small Cell Lung Cancer,
Location: Montreal, Fairfax VA, Durham NC, Toronto,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05005403

Phase 1, Recruiting
FeaturedActive & Responsive

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

for
Bipolar I Disorder, Bipolar II Disorder
Location: New York NY, Pompano Beach FL, West Palm Beach FL,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT06696755

Phase 2, Recruiting
FeaturedActive & Responsive

A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume

for
Mid Face Volume Deficit
Location: New York NY, Latham NY, Baltimore MD, Arlington VA,
Sponsor: AbbVie

Sex: All

Age: 22+

Code: NCT06734351

Phase 3, Recruiting
FeaturedActive & Responsive

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder (GAD)
Location: Cromwell CT, Springfield MA, Brooklyn NY, Toms River NJ,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT06846320

Phase 2, Recruiting
FeaturedActive & Responsive

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

for
Migraine
Location: Miami FL, Los Angeles CA, Summerville SC, Tampa FL,
Sponsor: AbbVie

Sex: All

Age: 18 - 70

Code: NCT06602479

Phase 2, Recruiting
FeaturedActive & Responsive

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

for
Major Depressive Disorder
Location: New York NY, Hollywood FL, Miami FL, Orlando FL,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT07276997

Phase 2, Recruiting

PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy

for
Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04745949

Phase 2, Recruiting

A Study of MGC028 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, NSCLC Adenocarcinoma, Cholangiocarcinoma,
Location: Boston MA, New York NY, Grand Rapids MI, San Antonio TX,
Sponsor: MacroGenics

Sex: All

Age: 18+

Code: NCT06723236

Phase 1, Recruiting

Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A

for
Hemophilia A
Location: San Antonio TX, Seattle WA, San Diego CA
Sponsor: Washington Institute for Coagulation

Sex: Male

Age: 16+

Code: NCT04131036

Recruiting

Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress

for
Covid19
Location: Brandon FL, Sarasota FL, Tulsa OK, Mesquite TX,
Sponsor: Sorrento Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04905836

Phase 2, Recruiting

Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors

for
Recurrent or Refractory Solid Tumors, Ewing Sarcoma,
Location: Cincinnati OH, Milwaukee WI, Dallas TX,
Sponsor: South Plains Oncology Consortium

Sex: All

Age: 1 - 20

Code: NCT02013336

Phase 1, Recruiting

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

for
mCRPC (Metastatic Castration-resistant Prostate Cancer),
Location: New York NY, Baltimore MD, Fairfax VA, Durham NC,
Sponsor: Pathos AI, Inc.

Sex: Male

Age: 18+

Code: NCT06785636

Phase 1, Phase 2, Recruiting

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

for
Hodgkin Lymphoma, B-Cell Lymphoma, Relapsed B-cell NHL
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05615636

Phase 2, Recruiting

Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients

for
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy
Location: Philadelphia PA, Charlottesville VA, Louisville KY,
Sponsor: Octapharma

Sex: All

Age: 2 - 17

Code: NCT04929236

Phase 3, Recruiting

Popular cities in Texas

With a broad healthcare network and leading medical research centers, Texas is a key location for a wide range of clinical trials. Major institutions such as MD Anderson Cancer Center, Baylor College of Medicine, UT Southwestern Medical Center, and Texas Heart Institute are at the forefront of these studies.

Why choose Texas for clinical trials?

Texas offers unique advantages for those participating in clinical trials. The state's diverse population provides a broad range of participants, which enhances the reliability and relevance of research findings. Texas is also known for its innovative research environment, with a strong focus on medical advancements and cutting-edge studies.

By choosing to participate in a clinical trial in Texas, you contribute to important medical research while benefiting from a well-established and supportive clinical research system.

Common conditions studied in Texas

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Texas